TXG (10x Genomics) Institutional Ownership: 108.91% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TXG 10x Genomics Inc TXG
60 GF Score
Price $43.74
GF Value $18.91
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Institutional Ownership?

10x Genomics TXG -1.71% 60 Institutional Ownership is 108.91% as of Jul. 19, 2026. GuruFocus rates TXG with a GF Score™ of 60/100 and a GF Value™ of $18.91 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, 10x Genomics's institutional ownership is 108.91%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, 10x Genomics's Insider Ownership is 2.53%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, 10x Genomics's Float Percentage Of Total Shares Outstanding is 67.34%.

10x Genomics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for 10x Genomics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics Institutional Ownership Chart

10x Genomics Historical Data

The historical data trend for 10x Genomics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 62.91 64.22 66.92 67.33 67.10 68.13 67.89 68.98 68.84 72.00
TXG
60GF Score
10x Genomics Inc TXG
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 108.91% mean?
10x Genomics (TXG) has a Institutional Ownership of 108.91% as of Jul. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on 10x Genomics and its competitors.
Is 10x Genomics' Institutional Ownership too high?
10x Genomics' current Institutional Ownership is 108.91%. Overall, 10x Genomics has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Institutional Ownership compare to DOCS and WAY?
10x Genomics' Institutional Ownership of 108.91% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Healthcare Providers & Services company?
A good Institutional Ownership depends on the Healthcare Providers & Services industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on 10x Genomics and its competitors. 10x Genomics's current Institutional Ownership is 108.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
Based on GuruFocus' analysis, 10x Genomics (TXG) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.91, compared to a current price of $43.74 — trading 131.3% above its estimated fair value. The current Institutional Ownership is 108.91%. 10x Genomics' overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For 10x Genomics (TXG), the current Institutional Ownership is 108.91% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of $43.74 is trading 131.3% above its estimated GF Value™ of $18.91. GuruFocus considers 10x Genomics to be Significantly Overvalued.

Key valuation signals for TXG:

  • Institutional Ownership: 108.91%
  • GF Value™: $18.91 vs. price of $43.74 (131.3% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges 0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
60GF Score

Get the complete analysis for TXG

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.74
Price
$18.91
GF Value